Fernanda Tovar-Moll
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Fernanda Tovar-Moll has a total of 422 co-authors. Here are the top co-authors by number of shared publications:
- Erika Carvalho Rodrigues
D'Or Institute for Research and Education, IDOR
8 shared publications Paulo Mattos
D'Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil, 22281-100
7 shared publicationsRoberto Lent
D’Or Institute of Research and Education (IDOR) , Rio de Janeiro 22281-100, Brazil Institute of Biomedical Sciences, Federal University of Rio de Janeiro , Rio de Janeiro 21941-902, Brazil
7 shared publicationsJorge Moll
The D'Or Institute for Research & Education (IDOR), Brazil
6 shared publications- Stevens Kastrup Rehen
D’Or Institute for Research and Education (IDOR), Rio de Janeiro, Brazil
6 shared publications - Theo Marins
Institute of Psychology, University of Graz, Graz, Austria
6 shared publications
Latest Publications
- 24 September 2026
- Published by Springer Nature in Nature Neuroscience
- Vol. 29 (10) , 2397-2407
Reconciling global collaboration and data sovereignty in neuroscience
As artificial intelligence (AI) elevates the economic and strategic value of data, governments are intensifying efforts to regulate the collection, use and cross-border transfer of personal information. Data are increasingly treated as national assets, subject to legal, economic and geopolitical controls. These shifts are reshaping scientific research, particularly in neuroscience and brain health, where progress depends on access to large, diverse and internationally distributed datasets. In parallel, advances in neuroimaging, neurotechnology and computational modeling are enabling population-scale neuroscience and the generation of AI-ready brain datasets. These developments further increase the strategic importance of neural data, amplifying both their scientific value and their governance complexity. The convergence of these trends exposes a fundamental tension between the need for an open science culture and data sovereignty. Without coordinated responses, these dynamics risk limiting representation, slowing innovation and reinforcing global inequities in brain health research. Here we argue that neuroscience requires an international data governance coordinating body capable of aligning research and regulatory priorities. In addition to outlining the distinct challenges posed by neural data, we propose strategies to support secure, equitable and sustainable global collaboration, as well as practical governance instruments to enable coordinated implementation across jurisdictions.
- 24 September 2026
- Published by Springer Nature in Nature Neuroscience
- Vol. 29 (10) , 2397-2407
Reconciling global collaboration and data sovereignty in neuroscience
As artificial intelligence (AI) elevates the economic and strategic value of data, governments are intensifying efforts to regulate the collection, use and cross-border transfer of personal information. Data are increasingly treated as national assets, subject to legal, economic and geopolitical controls. These shifts are reshaping scientific research, particularly in neuroscience and brain health, where progress depends on access to large, diverse and internationally distributed datasets. In parallel, advances in neuroimaging, neurotechnology and computational modeling are enabling population-scale neuroscience and the generation of AI-ready brain datasets. These developments further increase the strategic importance of neural data, amplifying both their scientific value and their governance complexity. The convergence of these trends exposes a fundamental tension between the need for an open science culture and data sovereignty. Without coordinated responses, these dynamics risk limiting representation, slowing innovation and reinforcing global inequities in brain health research. Here we argue that neuroscience requires an international data governance coordinating body capable of aligning research and regulatory priorities. In addition to outlining the distinct challenges posed by neural data, we propose strategies to support secure, equitable and sustainable global collaboration, as well as practical governance instruments to enable coordinated implementation across jurisdictions.
- Open Access
- 24 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Regional, functional and transcriptomic decoding of multidimensional brain structure alterations in obsessive-compulsive disorder
Studies of brain morphology in mental illness often focus on a few neuroimaging phenotypes. Here we present a comprehensive morphological characterization in obsessive-compulsive disorder (OCD) in a large sample (2255 OCD, 2264 controls) using nine cortical and four subcortical phenotypes, including several not previously examined in OCD, among them a subcortical structural similarity network phenotype developed here. Spatially distinct regional alterations emerged across structural phenotypes: cortical curvature alterations in default mode and frontoparietal networks, increased structural similarity network node degree in sensorimotor regions, widespread volume reductions associated with medication use, and localized subcortical shape alterations. In brain-behavior predictive models, curvature phenotypes showed the strongest associations with clinical features. Cortical alterations, especially in structural similarity networks, were associated with specific gene expression patterns, implicating dysregulation of excitatory neurons. RNA-sequencing data from tissue collected during functional neurosurgery revealed that genes downregulated in the dorsolateral prefrontal cortex in OCD contributed to the gene expression patterns linked to cortical alterations. Previously reported differentially expressed genes from postmortem brain studies of OCD also contributed. These findings support the importance of a comprehensive approach to characterizing brain morphology and suggest that cortical curvature and structural similarity alterations reflect key pathophysiological processes in OCD.
- 24 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessRegional, functional and transcriptomic decoding of multidimensional brain structure alterations in obsessive-compulsive disorder
Studies of brain morphology in mental illness often focus on a few neuroimaging phenotypes. Here we present a comprehensive morphological characterization in obsessive-compulsive disorder (OCD) in a large sample (2255 OCD, 2264 controls) using nine cortical and four subcortical phenotypes, including several not previously examined in OCD, among them a subcortical structural similarity network phenotype developed here. Spatially distinct regional alterations emerged across structural phenotypes: cortical curvature alterations in default mode and frontoparietal networks, increased structural similarity network node degree in sensorimotor regions, widespread volume reductions associated with medication use, and localized subcortical shape alterations. In brain-behavior predictive models, curvature phenotypes showed the strongest associations with clinical features. Cortical alterations, especially in structural similarity networks, were associated with specific gene expression patterns, implicating dysregulation of excitatory neurons. RNA-sequencing data from tissue collected during functional neurosurgery revealed that genes downregulated in the dorsolateral prefrontal cortex in OCD contributed to the gene expression patterns linked to cortical alterations. Previously reported differentially expressed genes from postmortem brain studies of OCD also contributed. These findings support the importance of a comprehensive approach to characterizing brain morphology and suggest that cortical curvature and structural similarity alterations reflect key pathophysiological processes in OCD.
- Open Access
- 1 May 2025
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 46, 101007
Comparison of cerebrospinal fluid biomarkers in patients with severe COVID-19 neurological outcomes and Alzheimer’s disease
- 1 May 2025
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 46, 101007
Open AccessComparison of cerebrospinal fluid biomarkers in patients with severe COVID-19 neurological outcomes and Alzheimer’s disease
- Open Access
- 25 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-11
Performance of plasma biomarkers for diagnosis and prediction of dementia in a Brazilian cohort
Despite remarkable progress in the biomarker field in recent years, local validation of plasma biomarkers of Alzheimer’s disease (AD) and dementia is still lacking in Latin America. In this longitudinal cohort study of 145 elderly Brazilians, we assess the diagnostic performance of plasma biomarkers, based on clinical diagnosis and CSF biomarker positivity. Follow-up data of up to 4.7 years were used to determine performance in predicting diagnostic conversions. Participants were clinically categorized as cognitively unimpaired (n = 49), amnestic mild cognitive impairment (n = 29), AD (n = 38), Lewy body dementia (n = 22), or vascular dementia (n = 7). Plasma Tau, Aβ40, Aβ42, NfL, GFAP, pTau231, pTau181 and pTau217 were measured on the SIMOA HD-X platform. Plasma pTau217 showed excellent performance determining CSF biomarker status in the cohort, either alone (ROC AUC = 0.94, 95% CI: [0.88–1.00]) or as a ratio to Aβ42 (ROC AUC = 0.98, 95% CI: [0.94–1.00]). This study comprises an initial step towards local validation and adoption of dementia biomarkers in Brazil.
- 25 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-11
Open AccessPerformance of plasma biomarkers for diagnosis and prediction of dementia in a Brazilian cohort
Despite remarkable progress in the biomarker field in recent years, local validation of plasma biomarkers of Alzheimer’s disease (AD) and dementia is still lacking in Latin America. In this longitudinal cohort study of 145 elderly Brazilians, we assess the diagnostic performance of plasma biomarkers, based on clinical diagnosis and CSF biomarker positivity. Follow-up data of up to 4.7 years were used to determine performance in predicting diagnostic conversions. Participants were clinically categorized as cognitively unimpaired (n = 49), amnestic mild cognitive impairment (n = 29), AD (n = 38), Lewy body dementia (n = 22), or vascular dementia (n = 7). Plasma Tau, Aβ40, Aβ42, NfL, GFAP, pTau231, pTau181 and pTau217 were measured on the SIMOA HD-X platform. Plasma pTau217 showed excellent performance determining CSF biomarker status in the cohort, either alone (ROC AUC = 0.94, 95% CI: [0.88–1.00]) or as a ratio to Aβ42 (ROC AUC = 0.98, 95% CI: [0.94–1.00]). This study comprises an initial step towards local validation and adoption of dementia biomarkers in Brazil.
- Open Access
Neurological, Radiological, Visual, and Auditory Findings in Children with Intrauterine Exposure to the Zika Virus
This study aims to describe neurological, visual, and auditory findings in children whose mothers had confirmed Zika virus (ZIKV) infection during pregnancy, with most of these children not presenting congenital microcephaly; Methods: an observational, longitudinal, and prospective study was conducted in Rio de Janeiro, Brazil, from March 2015 to January 2017, involving children with in utero exposure to Zika virus, following from birth up to 30 months of age. Results: Of the 2882 pregnant women admitted, 116 had a suspected ZIKV infection, of whom 33 had laboratory confirmation. Only one child presented with congenital microcephaly. Despite this, neurodevelopment delay was observed in 36.4% of children evaluated, radiological abnormalities in 29.1%, auditory abnormalities in 8.3%, and ophthalmological abnormalities in 10%. Conclusions: Newborns of mothers with confirmed ZIKV infection during pregnancy may present with varying degrees of visual, auditory, and neurological impairment, despite the presence of congenital microcephaly.
Open AccessNeurological, Radiological, Visual, and Auditory Findings in Children with Intrauterine Exposure to the Zika Virus
This study aims to describe neurological, visual, and auditory findings in children whose mothers had confirmed Zika virus (ZIKV) infection during pregnancy, with most of these children not presenting congenital microcephaly; Methods: an observational, longitudinal, and prospective study was conducted in Rio de Janeiro, Brazil, from March 2015 to January 2017, involving children with in utero exposure to Zika virus, following from birth up to 30 months of age. Results: Of the 2882 pregnant women admitted, 116 had a suspected ZIKV infection, of whom 33 had laboratory confirmation. Only one child presented with congenital microcephaly. Despite this, neurodevelopment delay was observed in 36.4% of children evaluated, radiological abnormalities in 29.1%, auditory abnormalities in 8.3%, and ophthalmological abnormalities in 10%. Conclusions: Newborns of mothers with confirmed ZIKV infection during pregnancy may present with varying degrees of visual, auditory, and neurological impairment, despite the presence of congenital microcephaly.
- Open Access
- 31 December 2024
- Published by MDPI AG in Preprints.org
Neurological, Radiological, Visual, and Auditory Alterations in Children with Intrauterine Exposure to the Zika Virus
This study aims to describe neurological, visual, and auditory alterations in children whose mothers had confirmed Zika virus (ZIKV) infection during pregnancy, with most of these children not presenting congenital microcephaly; Methods: an observational, longitudinal, and prospective study was conducted, involving children with in utero exposure to Zika virus, following from birth up to 30 months of age; Results: of the 2,882 pregnant women admitted, 116 had a suspected ZIKV infection, of whom 33 had laboratory confirmation. Only one child presented with congenital microcephaly. Despite this, neurodevelopment delay was observed in 36.4% of children evaluated, radiological abnormalities in 29.1%, auditory abnormalities in 8.3%, and ophthalmological abnormalities in 10%; Conclusions: newborns of mothers with confirmed ZIKV infection during pregnancy may present with varying degrees of visual, auditory, and neurological impairment, despite the presence of congenital microcephaly.
- 31 December 2024
- Published by MDPI AG in Preprints.org
Open AccessNeurological, Radiological, Visual, and Auditory Alterations in Children with Intrauterine Exposure to the Zika Virus
This study aims to describe neurological, visual, and auditory alterations in children whose mothers had confirmed Zika virus (ZIKV) infection during pregnancy, with most of these children not presenting congenital microcephaly; Methods: an observational, longitudinal, and prospective study was conducted, involving children with in utero exposure to Zika virus, following from birth up to 30 months of age; Results: of the 2,882 pregnant women admitted, 116 had a suspected ZIKV infection, of whom 33 had laboratory confirmation. Only one child presented with congenital microcephaly. Despite this, neurodevelopment delay was observed in 36.4% of children evaluated, radiological abnormalities in 29.1%, auditory abnormalities in 8.3%, and ophthalmological abnormalities in 10%; Conclusions: newborns of mothers with confirmed ZIKV infection during pregnancy may present with varying degrees of visual, auditory, and neurological impairment, despite the presence of congenital microcephaly.
- Open Access
- 13 June 2024
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 39, 100805
Changes in neuroinflammatory biomarkers correlate with disease severity and neuroimaging alterations in patients with COVID-19 neurological complications
- 13 June 2024
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 39, 100805
Open AccessChanges in neuroinflammatory biomarkers correlate with disease severity and neuroimaging alterations in patients with COVID-19 neurological complications
- Open Access
- 8 February 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-11
Cortical folding correlates to aging and Alzheimer’s Disease’s cognitive and CSF biomarkers
This manuscript presents the quantification and correlation of three aspects of Alzheimer’s Disease evolution, including structural, biochemical, and cognitive assessments. We aimed to test a novel structural biomarker for neurodegeneration based on a cortical folding model for mammals. Our central hypothesis is that the cortical folding variable, representative of axonal tension in white matter, is an optimal discriminator of pathological aging and correlates with altered loadings in Cerebrospinal Fluid samples and a decline in cognition and memory. We extracted morphological features from T1w 3T MRI acquisitions using FreeSurfer from 77 Healthy Controls (age = 66 ± 8.4, 69% females), 31 Mild Cognitive Impairment (age = 72 ± 4.8, 61% females), and 13 Alzheimer’s Disease patients (age = 77 ± 6.1, 62% females) of recruited volunteers in Brazil to test its discriminative power using optimal cut-point analysis. Cortical folding distinguishes the groups with reasonable accuracy (Healthy Control-Alzheimer’s Disease, accuracy = 0.82; Healthy Control-Mild Cognitive Impairment, accuracy = 0.56). Moreover, Cerebrospinal Fluid biomarkers (total Tau, A $$\beta $$ 1-40, A $$\beta $$ 1-42, and Lipoxin) and cognitive scores (Cognitive Index, Rey’s Auditory Verbal Learning Test, Trail Making Test, Digit Span Backward) were correlated with the global neurodegeneration in MRI aiming to describe health, disease, and the transition between the two states using morphology.- 8 February 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-11
Open AccessCortical folding correlates to aging and Alzheimer’s Disease’s cognitive and CSF biomarkers
This manuscript presents the quantification and correlation of three aspects of Alzheimer’s Disease evolution, including structural, biochemical, and cognitive assessments. We aimed to test a novel structural biomarker for neurodegeneration based on a cortical folding model for mammals. Our central hypothesis is that the cortical folding variable, representative of axonal tension in white matter, is an optimal discriminator of pathological aging and correlates with altered loadings in Cerebrospinal Fluid samples and a decline in cognition and memory. We extracted morphological features from T1w 3T MRI acquisitions using FreeSurfer from 77 Healthy Controls (age = 66 ± 8.4, 69% females), 31 Mild Cognitive Impairment (age = 72 ± 4.8, 61% females), and 13 Alzheimer’s Disease patients (age = 77 ± 6.1, 62% females) of recruited volunteers in Brazil to test its discriminative power using optimal cut-point analysis. Cortical folding distinguishes the groups with reasonable accuracy (Healthy Control-Alzheimer’s Disease, accuracy = 0.82; Healthy Control-Mild Cognitive Impairment, accuracy = 0.56). Moreover, Cerebrospinal Fluid biomarkers (total Tau, A $$\beta $$ 1-40, A $$\beta $$ 1-42, and Lipoxin) and cognitive scores (Cognitive Index, Rey’s Auditory Verbal Learning Test, Trail Making Test, Digit Span Backward) were correlated with the global neurodegeneration in MRI aiming to describe health, disease, and the transition between the two states using morphology. - 9 November 2023
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 34 (1)
Direct interhemispheric cortical communication via thalamic commissures: a new white matter pathway in the primate brain
Cortical neurons of eutherian mammals project to the contralateral hemisphere, crossing the midline primarily via the corpus callosum and the anterior, posterior, and hippocampal commissures. We recently reported and named the thalamic commissures (TCs) as an additional interhemispheric axonal fiber pathway connecting the cortex to the contralateral thalamus in the rodent brain. Here, we demonstrate that TCs also exist in primates and characterize the connectivity of these pathways with high-resolution diffusion-weighted MRI, viral axonal tracing, and fMRI. We present evidence of TCs in both New World (Callithrix jacchus and Cebus apella) and Old World primates (Macaca mulatta). Further, like rodents, we show that the TCs in primates develop during the embryonic period, forming anatomical and functionally active connections of the cortex with the contralateral thalamus. We also searched for TCs in the human brain, showing their presence in humans with brain malformations, although we could not identify TCs in healthy subjects. These results pose the TCs as a vital fiber pathway in the primate brain, allowing for more robust interhemispheric connectivity and synchrony and serving as an alternative commissural route in developmental brain malformations.
- 9 November 2023
- Published by Oxford University Press (OUP) in Cerebral Cortex
- Vol. 34 (1)
Direct interhemispheric cortical communication via thalamic commissures: a new white matter pathway in the primate brain
Cortical neurons of eutherian mammals project to the contralateral hemisphere, crossing the midline primarily via the corpus callosum and the anterior, posterior, and hippocampal commissures. We recently reported and named the thalamic commissures (TCs) as an additional interhemispheric axonal fiber pathway connecting the cortex to the contralateral thalamus in the rodent brain. Here, we demonstrate that TCs also exist in primates and characterize the connectivity of these pathways with high-resolution diffusion-weighted MRI, viral axonal tracing, and fMRI. We present evidence of TCs in both New World (Callithrix jacchus and Cebus apella) and Old World primates (Macaca mulatta). Further, like rodents, we show that the TCs in primates develop during the embryonic period, forming anatomical and functionally active connections of the cortex with the contralateral thalamus. We also searched for TCs in the human brain, showing their presence in humans with brain malformations, although we could not identify TCs in healthy subjects. These results pose the TCs as a vital fiber pathway in the primate brain, allowing for more robust interhemispheric connectivity and synchrony and serving as an alternative commissural route in developmental brain malformations.
- Open Access
- 16 June 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S2)
Epigenetic modulation of cognitive function: toward new treatment models
Background: The current translational work is an outgrowth of a mechanistic framework in rodents with cognitive deficits and depressive‐like traits, wherein the levels of the pivotal mitochondrial metabolite acetyl‐L‐carnitine (LAC) are decreased and signal to the brain abnormal activity of histone acetyltransferase and expression of genes key for neuronal plasticity, such as mGlu2 (a key inhibitor of glutamate release). Yet, the role of this emerging signaling pathway of brain plasticity remains to be fully determined in subjects with cognitive impairments (CI).Method: Here we performed ultraperformance liquid chromatography–tandem mass spectrometry (UPLC‐MS/MS) to measure peripheral levels of LAC and the related mitochondrial metabolite free‐carnitine in a cohort of subjects with cognitive impairments (CI, n = 29) and age‐ and sex‐matched cognitively healthy controls (HC, n = 32). Next, we performed multiple regression analysis to investigate the relationship between mitochondrial metabolism of LAC and clinical characteristics.Result: Decreased levels of the pivotal mitochondrial metabolite LAC in subjects with CI as compared to age‐ and sex‐matched HC subjects (p = 0.02), with potential sex differences in peripheral levels of free‐carnitine (p = 0.03). Incorporation of these new measures into a canonical biomarker model improved diagnostic accuracyConclusion: Our new translational findings suggest that a deficiency of LAC, and potential sex differences in free‐carnitine levels, might define clinical phenotypes of CI. Ongoing studies are ascertaining the role between LAC levels, and its main metabolite free‐carnitine, in relation to specific cognitive domains.
- 16 June 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S2)
Open AccessEpigenetic modulation of cognitive function: toward new treatment models
Background: The current translational work is an outgrowth of a mechanistic framework in rodents with cognitive deficits and depressive‐like traits, wherein the levels of the pivotal mitochondrial metabolite acetyl‐L‐carnitine (LAC) are decreased and signal to the brain abnormal activity of histone acetyltransferase and expression of genes key for neuronal plasticity, such as mGlu2 (a key inhibitor of glutamate release). Yet, the role of this emerging signaling pathway of brain plasticity remains to be fully determined in subjects with cognitive impairments (CI).Method: Here we performed ultraperformance liquid chromatography–tandem mass spectrometry (UPLC‐MS/MS) to measure peripheral levels of LAC and the related mitochondrial metabolite free‐carnitine in a cohort of subjects with cognitive impairments (CI, n = 29) and age‐ and sex‐matched cognitively healthy controls (HC, n = 32). Next, we performed multiple regression analysis to investigate the relationship between mitochondrial metabolism of LAC and clinical characteristics.Result: Decreased levels of the pivotal mitochondrial metabolite LAC in subjects with CI as compared to age‐ and sex‐matched HC subjects (p = 0.02), with potential sex differences in peripheral levels of free‐carnitine (p = 0.03). Incorporation of these new measures into a canonical biomarker model improved diagnostic accuracyConclusion: Our new translational findings suggest that a deficiency of LAC, and potential sex differences in free‐carnitine levels, might define clinical phenotypes of CI. Ongoing studies are ascertaining the role between LAC levels, and its main metabolite free‐carnitine, in relation to specific cognitive domains.